Rigel Pharmaceuticals Inc (RIGL)
EBITDA Growth
-59.64%
Quarterly · Period ending:
RIGL EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-59.64%period ending
Latest reported-59.64%period ending
RIGL Quarterly EBITDA YoY % (-185.07% → -59.64%)
Year-over-year change
High-resolution chart · PNG
RIGL ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -283.1535% | |
| -185.0719% |